Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Clinical trial NCT00948428 · COMPLETED

Trial details

NCT number: NCT00948428
Sponsor: Actavis Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratoses

Start date: 2008-05-01
Primary completion: 2009-03-01
Enrollment: 462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.